{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:52:11Z","timestamp":1760057531726,"version":"build-2065373602"},"reference-count":63,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute Of General Medical Sciences of the National Institutes of Health","award":["R16GM146679"],"award-info":[{"award-number":["R16GM146679"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background: As cannabis becomes legal in several U.S. states, the risk of THC-induced tachycardia increases. This study aimed to develop and verify a physiologically based pharmacokinetic\u2013pharmacodynamic (PBPK-PD) model to assess the impact of THC and its active metabolite, 11-hydroxy-THC (11-OH-THC), on the heart rate of healthy adults. Methods: A PBPK-PD model for intravenous (IV) 11-OH-THC administration was first developed. Secondly, a PBPK-PD model for IV THC, combined with the metabolized 11-OH-THC, was established, verified, and validated. Direct PD models driven by the plasma, brain, and heart concentrations of THC and 11-OH-THC predicted using our previously verified PBPK model were tested for model development. Finally, the risks of tachycardia at a rest condition from various doses of oral and inhaled THC were simulated for 500 individuals aged 18\u201365 years, with a sex ratio of 1:1 and a baseline heart rate of 70 beats per minute. Results: The PD model was best described by a direct nonlinear Emax model driven by the sum of the total THC and 11-OH-THC concentrations in their effect compartments linked to their heart compartments. In 42 simulated dosing regimens with THC doses ranging from 2 to 69.4 mg, 97% of the observed heart rates or heart rate changes following THC administration fell within the 5th to 95th percentiles of the model-predicted values. Similarly, for two simulated 11-OH-THC IV doses, 93% of the observations fell within this range. Simulations indicated that half of the simulated population would experience tachycardia at doses of 60 mg and 15 mg of THC for oral and inhaled administration, respectively. The simulated risks of tachycardia based on specific conditions should be interpreted with caution. Conclusions: Our verified PBPK-PD model successfully describes the heart rate changes in healthy adults after IV, oral, and inhaled THC administration. This model provides a tool to predict the effects of THC and its primary metabolite on heart rates, offering valuable insights for assessing the risk of tachycardia in both clinical and recreational cannabis use.<\/jats:p>","DOI":"10.3390\/pharmaceutics17020237","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T04:37:04Z","timestamp":1739335024000},"page":"237","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quantifying Heart Rate Changes After Delta-9-Tetrahydrocannabinol Administration Using a PBPK-PD Model in Healthy Adults"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3137-5529","authenticated-orcid":false,"given":"Lixuan","family":"Qian","sequence":"first","affiliation":[{"name":"Department of Chemistry, York College, City University of New York, Jamaica, NY 11451, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Chemistry, York College, City University of New York, Jamaica, NY 11451, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1002\/jcp.27725","article-title":"Medical Cannabis: A plurimillennial history of an evergreen","volume":"234","author":"Pisanti","year":"2019","journal-title":"J. Cell. Physiol."},{"doi-asserted-by":"crossref","unstructured":"Pagano, C., Navarra, G., Coppola, L., Avilia, G., Bifulco, M., and Laezza, C. (2022). Cannabinoids: Therapeutic Use in Clinical Practice. Int. J. Mol. Sci., 23.","key":"ref_2","DOI":"10.3390\/ijms23063344"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/cpt.2470","article-title":"Cannabis for Medical Use: Clinical Pharmacology Perspectives on Scientific and Regulatory Challenges","volume":"111","author":"Zhou","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"unstructured":"(2024, December 26). Michael Conaway, C. H.R.2\u2014Agriculture Improvement Act of 2018, Available online: https:\/\/www.congress.gov\/bill\/115th-congress\/house-bill\/2\/text\/enr.","key":"ref_4"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in Cannabis Potency Over the Last 2 Decades (1995\u20132014): Analysis of Current Data in the United States","volume":"79","author":"ElSohly","year":"2016","journal-title":"Biol. Psychiatry"},{"doi-asserted-by":"crossref","unstructured":"ElSohly, M.A., Majumdar, C.G., Chandra, S., and Radwan, M.M. (2024). A 10-year trend in Cannabis potency (2013\u20132022) in different geographical regions of the United States of America. Front. Public. Health, 12.","key":"ref_6","DOI":"10.3389\/fpubh.2024.1442522"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijcard.2006.08.001","article-title":"Marijuana as a trigger of cardiovascular events: Speculation or scientific certainty?","volume":"118","author":"Aryana","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jacc.2015.08.038","article-title":"Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management","volume":"66","author":"Gopinathannair","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"doi-asserted-by":"crossref","unstructured":"Weresa, J., Pedzinska-Betiuk, A., Minczuk, K., Malinowska, B., and Schlicker, E. (2022). Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?. Cells, 11.","key":"ref_9","DOI":"10.3390\/cells11071142"},{"doi-asserted-by":"crossref","unstructured":"Qian, L., Beers, J.L., Jackson, K.D., and Zhou, Z. (2024). CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions. Pharmaceutics, 16.","key":"ref_10","DOI":"10.3390\/pharmaceutics16040484"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0022-3565(25)38122-X","article-title":"Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities","volume":"265","author":"Compton","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"doi-asserted-by":"crossref","unstructured":"Wiley, J.L., Barrus, D.G., Farquhar, C.E., Lefever, T.W., and Gamage, T.F. (2021). Sex, species and age: Effects of rodent demographics on the pharmacology of \u22069-tetrahydrocanabinol. Prog. Neuropsychopharmacol. Biol. Psychiatry, 106.","key":"ref_12","DOI":"10.1016\/j.pnpbp.2020.110064"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/15563650.2019.1655569","article-title":"Cannabis intoxication after accidental ingestion in infants: Urine and plasma concentrations of Delta-9-tetrahydrocannabinol (THC), THC-COOH and 11-OH-THC in 10 patients","volume":"58","author":"Guidet","year":"2020","journal-title":"Clin. Toxicol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1126\/science.177.4049.633","article-title":"Intravenous injection in man of 9-tetrahydrocannabinol and 11-OH-9-tetrahydrocannabinol","volume":"177","author":"Timmons","year":"1972","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/BF01930433","article-title":"A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man","volume":"29","author":"Timmons","year":"1973","journal-title":"Experientia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0379-0738(01)00609-0","article-title":"Acute cardiovascular fatalities following Cannabis use","volume":"124","author":"Bachs","year":"2001","journal-title":"Forensic Sci. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/clc.21962","article-title":"Cannabinoids and atherosclerotic coronary heart disease","volume":"35","author":"Singla","year":"2012","journal-title":"Clin. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cmet.2010.02.015","article-title":"CB1 signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance","volume":"11","author":"Quarta","year":"2010","journal-title":"Cell Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.npp.1301643","article-title":"Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of Cannabis","volume":"33","author":"Ranganathan","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/0269881108089870","article-title":"Modelling of the concentration\u2014Effect relationship of THC on central nervous system parameters and heart rate\u2014Insight into its mechanisms of action and a tool for clinical research and development of cannabinoids","volume":"22","author":"Strougo","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/cpt1979254440","article-title":"Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: Autonomic nervous mechanisms","volume":"25","author":"Benowitz","year":"1979","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.CIR.53.4.703","article-title":"The effects of delta-9-tetrahydrocannabinol (Cannabis) on cardiac performance with and without beta blockade","volume":"53","author":"Kanakis","year":"1976","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-2999(73)90078-2","article-title":"Hemodynamic and myocardial effects of (\u2212)-delta9-trans-tetrahydrocannabinol in anesthetized dogs","volume":"24","author":"Cavero","year":"1973","journal-title":"Eur. J. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0022-3565(24)29602-6","article-title":"Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart","volume":"297","author":"Szabo","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/FJC.0000000000000613","article-title":"Effect of Cannabinoid Receptor Agonists on Isolated Rat Atria","volume":"72","author":"Maggo","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1872312811206020102","article-title":"Single-dose pharmacokinetics and tolerability of oral delta-9-tetrahydrocannabinol in patients with amyotrophic lateral sclerosis","volume":"6","author":"Joerger","year":"2012","journal-title":"Drug Metab. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/psp4.12134","article-title":"Applied Concepts in PBPK Modeling: How to Build a PBPK\/PD Model","volume":"5","author":"Kuepfer","year":"2016","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1600-0447.1999.tb10916.x","article-title":"Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration","volume":"100","author":"Mathew","year":"1999","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1378\/chest.70.4.480","article-title":"Effect of oral administration of delta-tetrahydrocannabinol on airway mechanics in normal and asthmatic subjects","volume":"70","author":"Abboud","year":"1976","journal-title":"Chest"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0091-3057(97)00414-0","article-title":"Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol","volume":"59","author":"Kirk","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/sj.npp.1300176","article-title":"Effects of THC on behavioral measures of impulsivity in humans","volume":"28","author":"McDonald","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2982.2010.01587.x","article-title":"The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients","volume":"23","author":"Klooker","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/s41386-022-01281-w","article-title":"Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC","volume":"47","author":"Murray","year":"2022","journal-title":"Neuropsychopharmacology"},{"doi-asserted-by":"crossref","unstructured":"Shabani, M., Ilaghi, M., Naderi, R., and Razavinasab, M. (2023). The hyperexcitability of laterodorsal tegmentum cholinergic neurons accompanies adverse behavioral and cognitive outcomes of prenatal stress. Sci. Rep., 13.","key":"ref_34","DOI":"10.1038\/s41598-023-33016-2"},{"key":"ref_35","first-page":"57","article-title":"Bronchial effects of aerosolized delta 9-tetrahydrocannabinol in healthy and asthmatic subjects","volume":"115","author":"Tashkin","year":"1977","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00426599","article-title":"Propranolol effects on acute marihuana intoxication in man","volume":"52","author":"Sulkowski","year":"1977","journal-title":"Psychopharmacology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/cpt1976193300","article-title":"Influence of cannabidiol on delta-9-tetrahydrocannabinol effects","volume":"19","author":"Dalton","year":"1976","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/cpt1976203350","article-title":"Effects of marihuana-dextroamphetamine combination","volume":"20","author":"Evans","year":"1976","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0091-3057(89)90534-0","article-title":"Breathhold duration and response to marijuana smoke","volume":"33","author":"Zacny","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0091-3057(89)90369-9","article-title":"Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance","volume":"34","author":"Heishman","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1530-0277.1988.tb00193.x","article-title":"Interaction between marihuana and ethanol: Effects on psychomotor performance","volume":"12","author":"Hicks","year":"1988","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0376-8716(85)90002-X","article-title":"\u2018Hangover\u2019 effects the morning after marijuana smoking","volume":"15","author":"Chait","year":"1985","journal-title":"Drug Alcohol. Depend."},{"key":"ref_43","first-page":"157","article-title":"The neurophysiological basis of the marijuana experience","volume":"108","author":"Low","year":"1973","journal-title":"Can. Med. Assoc. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000136375","article-title":"Comparative studies in man and in laboratory animals on 8- and 9-trans-tetrahydrocannabinol","volume":"9","author":"Karniol","year":"1973","journal-title":"Pharmacology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1056\/NEJM197308162890702","article-title":"Acute pulmonary physiologic effects of smoked marijuana and oral \u03949-tetrahydrocannabinol in healthy young men","volume":"289","author":"Tashkin","year":"1973","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1139\/y74-090","article-title":"Cardiovascular effects of marihuana in man","volume":"52","author":"Clark","year":"1974","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2125.1981.tb01294.x","article-title":"The seed and the soil: Effect of dosage, personality and starting state on the response to delta 9 tetrahydrocannabinol in man","volume":"12","author":"Ashton","year":"1981","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0091-3057(97)00386-9","article-title":"Acute and residual effects of marijuana in humans","volume":"60","author":"Fant","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/0091270004265699","article-title":"Effect of acute marijuana on cardiovascular function and central nervous system pharmacokinetics of [(15)O]water: Effect in occasional and chronic users","volume":"44","author":"Ponto","year":"2004","journal-title":"J. Clin. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/0269881108089581","article-title":"Effect of intrapulmonary tetrahydrocannabinol administration in humans","volume":"22","author":"Zuurman","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0269881108096509","article-title":"Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625","volume":"24","author":"Zuurman","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-008-1440-0","article-title":"Cognitive and psychomotor effects in males after smoking a combination of tobacco and Cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC)","volume":"204","author":"Hunault","year":"2009","journal-title":"Psychopharmacology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.neuroimage.2012.07.051","article-title":"Manipulating brain connectivity with \u03b4\u2079-tetrahydrocannabinol: A pharmacological resting state FMRI study","volume":"63","author":"Klumpers","year":"2012","journal-title":"Neuroimage"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/jat\/bkv012","article-title":"Smoked Cannabis\u2019 psychomotor and neurocognitive effects in occasional and frequent smokers","volume":"39","author":"Desrosiers","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00406-019-00978-2","article-title":"A randomised controlled trial of vaporised \u03949-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent Cannabis users: Acute intoxication effects","volume":"269","author":"Solowij","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e70119","DOI":"10.1111\/cts.70119","article-title":"Physiologically Based Pharmacokinetic Modeling of Cannabidiol, Delta-9-Tetrahydrocannabinol, and Their Metabolites in Healthy Adults After Administration by Multiple Routes","volume":"18","author":"Qian","year":"2025","journal-title":"Clin. Transl. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1124\/dmd.121.000505","article-title":"Tetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2)","volume":"49","author":"Chen","year":"2021","journal-title":"Drug Metab. Dispos."},{"unstructured":"Gabrielsson, J., and Weiner, D. (2016). Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications, Apotekarsocieteten. [5th ed.].","key":"ref_58"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1124\/dmd.115.065920","article-title":"Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification","volume":"43","author":"Sager","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0306-4603(89)90017-8","article-title":"Some physical characteristics of NIDA marijuana cigarettes","volume":"14","author":"Chait","year":"1989","journal-title":"Addict. Behav."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12995-024-00414-9","article-title":"Guideline for the application of heart rate and heart rate variability in occupational medicine and occupational health science","volume":"19","author":"Sammito","year":"2024","journal-title":"J. Occup. Med. Toxicol."},{"unstructured":"Eric, H.A. (2006). Tachyarrhythmias. Blueprints Cardiology, Lippincott Williams & Wilkins. [2nd ed.].","key":"ref_62"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"108129","DOI":"10.1016\/j.drugalcdep.2020.108129","article-title":"THC and CBD blood and brain concentrations following daily administration to adolescent primates","volume":"213","author":"Withey","year":"2020","journal-title":"Drug Alcohol. Depend."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/2\/237\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:31:53Z","timestamp":1760027513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/2\/237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["pharmaceutics17020237"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17020237","relation":{},"ISSN":["1999-4923"],"issn-type":[{"type":"electronic","value":"1999-4923"}],"subject":[],"published":{"date-parts":[[2025,2,12]]}}}